跳至主要内容
临床试验/NCT05687591
NCT05687591
已完成
不适用

Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast Asia Observational Study

Sarawak Heart Centre1 个研究点 分布在 1 个国家目标入组 104 人2022年10月1日

概览

阶段
不适用
干预措施
Amplatzer Amulet Left Atrial Appendage Occlusion Device
疾病 / 适应症
Atrial Fibrillation
发起方
Sarawak Heart Centre
入组人数
104
试验地点
1
主要终点
Residual interatrial shunt
状态
已完成
最后更新
2个月前

概览

简要总结

This is a prospective and retrospective, multicenter observational study where the study is being performed to explore on the short-term and long-term safety and efficacy of LAA occlusion with Amplatzer Amulet Device in Southeast Asia population on a real-world basis.

详细描述

The study is both retrospective and prospective, multicenter observational study for all patient indicated for LAAO with the Amplatzer Amulet device, involving subjects who had their occluder implanted, been recently implanted or intended to undergo the procedure may be considerd to participate in the study. The sample size is 100 and is based on the estimated number of recruitments from the participating centers. The study duration is 12 months of recruitment plus 1 year follow-up for outcomes. The outcomes are measured based on the objectives of the study: Primary objective: To explore on the short-term and long-term (1 year) safety and efficacy of LAA occlusion with the Amplatzer Amulet Device in Southeast Asia population on a real-world basis. Secondary objective: To compare the practice of LAA occlusion with Amplatzer Amulet Device in Southeast Asia population with the European registries. Exploratory objective: To explore the cost effectiveness of LAA occlusion with the Amplatzer Amulet Device in the Southeast Asia. Descriptive statistics includes percentage, mean with standard deviation, or median with interquartile range will be reported, whichever appropriate. Categorical variables will be analysed using chi-square test or Fisher's exact test. Continuous variables will be analysed using independent (two variables only) or ANOVA test (more than two variables), or Mann-Whitney test (two variables only) or Kruskal-Wallis test (more than two variables) depending on the nature of underlying distributions. Time dependent outcome data will be analysed using Kaplan-Meier survival analysis.

注册库
clinicaltrials.gov
开始日期
2022年10月1日
结束日期
2024年12月1日
最后更新
2个月前
研究类型
Observational
性别
All

研究者

发起方
Sarawak Heart Centre
责任方
Principal Investigator
主要研究者

Dr. Keng Tat Koh

Principal Investigator / Consultant Cardiologist and Electrophysiologist

Sarawak Heart Centre

入排标准

入选标准

  • 18 year of age or older
  • Documented paroxysmal, persistent, or permanent non-valvular atrial fibrillation
  • At high risk of stroke or systemic embolism defined as CHA2DS2-VASc score of more than or equal to 3
  • Deemed suitable for LAA occlusion by the treating physician, who might or might not be the investigator
  • Able to comply with the required medication regimen post-device implant
  • Able and willing to return for required follow-up visits and examinations

排除标准

  • With active endocarditis or other infections producing bacteremia
  • Where placement of the device would interfere with any intracardiac or intravascular structures
  • Reversible cause of AF (i.e. secondary to thyroid disorders, acute alcohol intoxication, trauma, recent major surgical procedures)
  • Hypersensitivity to any portion of the device material or individual components of the Amulet LAA closure device
  • Actively enrolled or plans to enroll in a concurrent clinical study in which the active treatment arm may confound the results of this trial
  • Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the patient's ability to participate in the clinical trial or to comply with follow up requireemnts, or impact the scientific soundness of the clinical trial results.

研究组 & 干预措施

Patients indicated for LAAO with the Amplatzer Amulet

All subjects who are indicated for LAAO with the Amplatzer Amulet are eligible for the study.

干预措施: Amplatzer Amulet Left Atrial Appendage Occlusion Device

结局指标

主要结局

Residual interatrial shunt

时间窗: 1 year

To determine if there is residual interatrial shunt occurs after the implantation of the occluder (Yes/No). This is visualized through TOE or CT scan or TOE and CT scan.

Device embolization

时间窗: 1 year

To determine if device embolization occurs (Yes/No). This is visualized through TOE or CT scan or TOE and CT scan

Device dislocation and device related thrombus

时间窗: 1 year

To determine if there is any device-associated thrombus occurs after the implantation of the occluder (Presence/Absence). This is visualized through TOE or CT scan or TOE and CT scan.

Peri-device leak

时间窗: 1 year

To determine if there is peri-device leak occurs after the implantation of the occluder (Yes/No). This is visualized through TOE or CT scan or TOE and CT scan.

Mortality

时间窗: 1 year

To determine the mortality at 1 year after LAA occluder implantation

Ischemic Stroke and TIA

时间窗: 1 year

To determine the rate of ischemic stroke and TIA at 1 year after LAA occluder implantation

Major adverse bleeding event

时间窗: 1 year

To determine the rate of major adverse bleeding event at 1 year after LAA occluder implantation

研究点 (1)

Loading locations...

相似试验